Literature DB >> 17080417

Update on the neurology of Parkinson's disease.

Clare J Fowler1.   

Abstract

The differential diagnosis of a patient with apparent Parkinson's Disease (PD) and bladder symptoms is considered and the bladder dysfunction of Multiple System Atrophy (MSA) is reviewed. Recent insights into the progression of the neuropathology of PD have enabled thinking about the stage of the disease at which bladder dysfunction is likely to occur and the expected clinical context of the problem. Bladder symptoms of neurological origin are likely in a patient who has had treated motor symptoms for some years and in whom the ongoing neuropathology has progressed beyond involvement of the basal ganglia, so that symptoms due to cortical dysfunction as well as the adverse effects of dopaminergic medication are also confounding factors. Bladder symptoms in a man with lesser neurological disability should be investigated to exclude underlying outflow obstruction. Possible management options are considered. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17080417     DOI: 10.1002/nau.20371

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  8 in total

1.  Early bladder dysfunction in multiple system atrophy: who seek shall find.

Authors:  Claire Richard; Gérard Amarenco; Jose-Alberto Palma; Horacio Kaufmann; Sophie Drapier; Xavier Gamé; Benjamin Brucker; Benoit Peyronnet
Journal:  Clin Auton Res       Date:  2019-11-08       Impact factor: 4.435

Review 2.  Urinary tract dysfunction in Parkinson's disease: a review.

Authors:  Lehana Yeo; Rajindra Singh; Mohan Gundeti; Jayanta M Barua; Junaid Masood
Journal:  Int Urol Nephrol       Date:  2011-05-07       Impact factor: 2.370

3.  Whole-Transcriptome Analysis of Mouse Models with MPTP-Induced Early Stages of Parkinson's Disease Reveals Stage-Specific Response of Transcriptome and a Possible Role of Myelin-Linked Genes in Neurodegeneration.

Authors:  A Kh Alieva; V S Zyrin; M M Rudenok; A A Kolacheva; M V Shulskaya; M V Ugryumov; P A Slominsky; M I Shadrina
Journal:  Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.590

4.  Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.

Authors:  Anelya Kh Alieva; Elena V Filatova; Anna A Kolacheva; Margarita M Rudenok; Petr A Slominsky; Mikhail V Ugrumov; Maria I Shadrina
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

Review 5.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

6.  [Atypical Parkinson syndromes].

Authors:  A Strzelczyk; J C Möller; M Stamelou; A Matusch; W H Oertel
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

Review 7.  Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.

Authors:  Anne Pavy-Le Traon; Nikki Cotterill; Gerard Amarenco; Susanne Duerr; Horacio Kaufmann; Heinz Lahrmann; François Tison; Gregor K Wenning; Christopher G Goetz; Werner Poewe; Cristina Sampaio; Anette Schrag; Olivier Rascol; Pablo Martinez-Martin; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2018-10-25

8.  Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson's disease.

Authors:  Stephanie C Knüpfer; Susanne A Schneider; Mareike M Averhoff; Carsten M Naumann; Günther Deuschl; Klaus-Peter Jünemann; Moritz F Hamann
Journal:  BMC Urol       Date:  2016-09-05       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.